Goldman Sachs’s Exact Sciences EXAS Stock Holding History

Goldman Sachs’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,000	Closed	-$1.93M	–	6644
2025 Q4	$1.93M	Hold	19,000	–	–	﹤0.01%	4622
2025 Q3	$1.04M	Buy	+19,000	New	+$949K	﹤0.01%	4993
2025 Q1	–	Sell	-22,900	Closed	-$1.29M	–	6154
2024 Q4	$1.29M	Hold	22,900	–	–	﹤0.01%	4636
2024 Q3	$1.56M	Buy	+22,900	New	+$1.29M	﹤0.01%	4359
2024 Q2	–	Sell	-3,000	Closed	-$207K	–	5729
2024 Q1	$207K	Sell	3,000 -25,000	-89%	-$1.58M	﹤0.01%	5101
2023 Q4	$2.07M	Buy	28,000 +12,000	+75%	+$787K	﹤0.01%	3895
2023 Q3	$1.09M	Hold	16,000	–	–	﹤0.01%	4211
2023 Q2	$1.5M	Buy	+16,000	New	+$1.25M	﹤0.01%	4067
2021 Q3	–	Sell	-50,000	Closed	-$6.22M	–	6308
2021 Q2	$6.22M	Buy	+50,000	New	+$5.97M	﹤0.01%	3145
2020 Q3	–	Sell	-9,000	Closed	-$782K	–	5376
2020 Q2	$782K	Hold	9,000	–	–	﹤0.01%	4123
2020 Q1	$522K	Sell	9,000 -7,000	-44%	-$568K	﹤0.01%	4187
2019 Q4	$1.48M	Buy	+16,000	New	+$1.41M	﹤0.01%	3868
2019 Q2	–	Sell	-87,200	Closed	-$7.55M	–	5186
2019 Q1	$7.55M	Buy	87,200 +70,800	+432%	+$6.03M	﹤0.01%	2655
2018 Q4	$1.03M	Buy	+16,400	New	+$1.13M	﹤0.01%	3951
2018 Q2	–	Sell	-8,700	Closed	-$351K	–	5757
2018 Q1	$351K	Sell	8,700 -47,700	-85%	-$2.33M	﹤0.01%	4697
2017 Q4	$2.96M	Buy	+56,400	New	+$3.01M	﹤0.01%	3459
2017 Q3	–	Sell	-121,000	Closed	-$4.28M	–	6706
2017 Q2	$4.28M	Sell	121,000 -289,300	-71%	-$8.93M	﹤0.01%	3193
2017 Q1	$9.69M	Buy	+410,300	New	+$8.13M	﹤0.01%	2435
2016 Q4	–	Sell	-8,100	Closed	-$150K	–	6937
2016 Q3	$150K	Sell	8,100 -23,400	-74%	-$412K	﹤0.01%	6005
2016 Q2	$386K	Buy	+31,500	New	+$237K	﹤0.01%	5104
2016 Q1	–	Sell	-133,000	Closed	-$1.23M	–	7137
2015 Q4	$1.23M	Sell	133,000 -75,000	-36%	-$697K	﹤0.01%	4094
2015 Q3	$3.74M	Buy	208,000 +55,700	+37%	+$1.28M	﹤0.01%	3151
2015 Q2	$4.53M	Buy	152,300 +42,300	+38%	+$1.06M	﹤0.01%	3051
2015 Q1	$2.42M	Sell	110,000 -580,000	-84%	-$14.7M	﹤0.01%	3590
2014 Q4	$18.9M	Buy	690,000 +534,100	+343%	+$13M	0.01%	1856
2014 Q3	$3.02M	Buy	+155,900	New	+$2.86M	﹤0.01%	3518
2014 Q1	–	Sell	-2,300	Closed	-$27K	–	6811
2013 Q4	$27K	Hold	2,300	–	–	﹤0.01%	6511
2013 Q3	$27K	Hold	2,300	–	–	﹤0.01%	6390
2013 Q2	$32K	Buy	+2,300	New	+$25K	﹤0.01%	6137

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Goldman Sachs's EXAS Position: Q1 2026 in Review

Goldman Sachs sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,410,459 shares — an estimated $143M sold.

Goldman Sachs first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $143M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Goldman Sachs reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Goldman Sachs sold 1,410,459 Exact Sciences shares in Q1 2026, an estimated $143M.
Goldman Sachs first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
Goldman Sachs's Exact Sciences position peaked at $143M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.